Fidelity provided a $4.8m second tranche after a first close featuring vehicles for Kyushu University and Osaka University.

J-Pharma, a Japan-based cancer therapy developer, has increased a series D round that included Kyushu University’s QB Capital unit and Osaka University-affiliated Osaka University Venture Capital. The second tranche of the round involved ¥500m ($4.8m) from Eight Roads Ventures and F-Prime Capital Partners, two venture capital vehicles for investment and financial services group Fidelity. The…

The rest of this content is only accessible to University Venturing: News, Data and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.